An Open-Label, Pilot Trial of HRG80™ Red Ginseng in Chronic Fatigue Syndrome, Fibromyalgia, and Post-Viral Fatigue

• Autori principali: Jacob Teitelbaum (Autore), Sarah Goudie (Autore)
• Natura: Libro
• Pubblicazione: MDPI AG, 2021-12-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Chronic fatigue syndrome and fibromyalgia (CFS/FMS) affect 2.1% of the world's population and ~10-25% of people who have had COVID-19. Previous clinical data suggested that a unique <i>Panax ginseng</i> (C.A. Meyer, family Araliaceae) root extract (HRG80™ Red Ginseng) often resulted...